TP53 is a tumor suppressor, designated the “guardian of the genome” because of its crucial role in maintaining genomic integrity (Figure 1).11–16 Although TP53 alterations are considered difficult to drug, their secondary effects, such as amplifications, might be important in that the resultant overexpression levels may be actionable. Here, TP53 is linked to neoplasm.